Atlas of Rheumatoid Arthritis (eBook)

Paul Emery (Herausgeber)

eBook Download: PDF

2015 | 2015
XI, 264 Seiten
Springer Healthcare Ltd. (Verlag)
978-1-907673-91-7 (ISBN)

Infos

Atlas of Rheumatoid Arthritis is a high-quality educational initiative, written by leaders in the field of rheumatology, containing a collection of approximately 150 relevant images, with extended descriptive captions and a comprehensive bibliography. The Atlas of Rheumatoid Arthritis will provide clinicians with a visual guide to rheumatoid arthritis, focusing on assessment, diagnosis and treatment, including newer research into the signalling pathways involved in the pathogenesis of RA, before focusing on the treatment of RA. Rheumatoid arthritis (RA) is the most common and most serious of the inflammatory arthritic disorders, and it dominates clinical rheumatological practice. Effective, early treatment is vital as this can slow the course of the disease and reduce joint damage. RA is usually treated using disease-modifying anti-rheumatic drugs (DMARDs), most commonly methotrexate. The newest treatments target the disease-causing immune elements specifically and directly.

Professor Paul Emery is the Arthritis Research UK Professor of Rheumatology and Director of

the Leeds Institute of Rheumatic and Musculoskeletal Medicine and the Director of the Leeds

Musculoskeletal Biomedical Research Unit at Leeds Teaching Hospitals Trust in Leeds, United

Kingdom. Professor Emery was the President of the European League Against Rheumatism

(EULAR) from 2009-2011 and has served on the editorial boards major rheumatology journals

including Rheumatology, Arthritis and Rheumatism, Annals of the Rheumatic Diseases, Clinical

and Experimental Rheumatology, and Clinical Rheumatology. He was the inaugural President of

International Extremity MRI Society (ISEMIR) and is a National Institute for Health Research

(NIHR) Senior Investigator. Professor Emery is a recipient of the Roche Biennial Award for

Clinical Rheumatology; the Rheumatology Hospital Doctor of the Year Award; the EULAR

Prize for outstanding contribution to rheumatology research; and the Carol Nachman Prize

for outstanding rheumatology research. Professor Emery's research interests center around the

immunopathogenesis and immunotherapy of rheumatoid arthritis, spondyloarthritis, and connective

tissue diseases. He has a special interest in the factors leading to persistent inflammation

and has published over 950 peer-reviewed articles in this area.

is the Arthritis Research UK Professor of Rheumatology and Director of

the Leeds Institute of Rheumatic and Musculoskeletal Medicine and the Director of the Leeds

Musculoskeletal Biomedical Research Unit at Leeds Teaching Hospitals Trust in Leeds, United

Kingdom. Professor Emery was the President of the European League Against Rheumatism

(EULAR) from 2009-2011 and has served on the editorial boards major rheumatology journals

including Rheumatology, Arthritis and Rheumatism, Annals of the Rheumatic Diseases, Clinical

and Experimental Rheumatology, and Clinical Rheumatology. He was the inaugural President of

International Extremity MRI Society (ISEMIR) and is a National Institute for Health Research

(NIHR) Senior Investigator. Professor Emery is a recipient of the Roche Biennial Award for

Clinical Rheumatology; the Rheumatology Hospital Doctor of the Year Award; the EULAR

Prize for outstanding contribution to rheumatology research; and the Carol Nachman Prize

for outstanding rheumatology research. Professor Emery's research interests center around the

immunopathogenesis and immunotherapy of rheumatoid arthritis, spondyloarthritis, and connective

tissue diseases. He has a special interest in the factors leading to persistent inflammation

and has published over 950 peer-reviewed articles in this area.

Inhalt

1. Classification of rheumatoid arthritis2. Pre-rheumatoid arthritisWhat is pre-rheumatoid arthritis? Risk factors for rheumatoid arthritis Systemic autoimmunity associated with rheumatoid arthritis Symptoms without clinical arthritis Unclassified arthritis 3. Early rheumatoid arthritisIntroduction Pathology in early rheumatoid arthritis Diagnosis of early rheumatoid arthritis Classification of rheumatoid arthritis Management of early rheumatoid arthritis Recommendations for the management of early rheumatoid arthritis4. Established rheumatoid arthritisIntroduction Stages of established rheumatoid arthritis Common clinical presentations Introduction Stages of established rheumatoid arthritis Common clinical presentations 5. Remission and rheumatoid arthritisIntroduction Defining remission Imaging remission Immune-mediated remission Drug-free remission Optimal dose reduction regimes for patients in remission Part TWO Imaging of Rheumatoid Arthritis6. Magnetic resonance imaging in rheumatoid arthritis Introduction Technical aspects Visualizing rheumatoid arthritis Diagnosing rheumatoid arthritis Monitoring disease activity and structural damage 7. Ultrasound imaging in rheumatoid arthritis 7. Ultrasound imaging in rheumatoid arthritis Introduction Ultrasound and rheumatoid arthritis Cartilage damage Management of rheumatoid arthritis with ultrasound: diagnosis, therapeutic follow-up, remission, and flare Conclusion 8. Dual energy X-ray absorptiometry in rheumatoid arthritisIntroduction Bone remodeling in rheumatoid arthritis Bone damage imaging in rheumatoid arthritis Treatment of bone loss in rheumatoid arthritis Part three Treatment of rheumatoid arthritis9. MethotrexateIntroduction Historical perspective Mechanism of action and pharmacokinetics Dosing Benefits Monitoring 10. ImmunotherapyIntroduction Nonbiologic disease-modifying antirheumatic drugsBiologic disease-modifying antirheumatic drugsCost-effectiveness of immunotherapy in early rheumatoid arthritisRecommendations for the use of disease-modifying antirheumatic drug therapiesSafety of immunotherapyProspective new targets for immunotherapy 11. RituximabB-cell development and differentiation Efficacy of rituximab in rheumatoid arthritis 12. Novel therapies in rheumatoid arthritis: small moleculesIntroduction Inhibiting intracellular signaling pathways Conclusion

Produkt-Details

• Erscheint lt. Verlag: 9.6.2015
• Zusatzinfo: XI, 264 p. 166 illus., 115 illus. in color.
• Verlagsort: Tarporley
• Sprache: englisch
• Themenwelt: Schulbuch / Wörterbuch ► Lexikon / Chroniken
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Geriatrie
• Themenwelt: Medizinische Fachgebiete ► Innere Medizin ► Rheumatologie
• Themenwelt: Medizinische Fachgebiete ► Radiologie / Bildgebende Verfahren ► Radiologie
• Schlagworte: Arthritis • DMARD • Rheumatoid Arthritis • rheumatology • Rheumatology Imaging
• ISBN-10: 1-907673-91-1 / 1907673911
• ISBN-13: 978-1-907673-91-7 / 9781907673917